ZYUS.V · ZYUS Life Sciences Corporation
Canada · RS rating 52 · As of 2026-10-14
| Price | 0.50 CAD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 52 / 94 / 57 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 9 / 37 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -33.6% |
| Distance from 52-week high | +33.3% |
| Market cap (USD) | $28.3M |